Searched for
HDFC AMC BLOCK DEAL
Lenskart block deal; Meesho's kirana pushLenskart has drawn fresh interest from major institutional investors. This and more in today's ETtech Top 5.- Lenskart shares in focus as Goldman Sachs, Morgan Stanley, others purchase stake in Rs 1,960 crore block dealLenskart Solutions saw significant stake activity as marquee investors bought Rs 1,960 crore in a block deal, with Platinum Jasmine A 2018 ...
- Goldman Sachs, Morgan Stanley and others buy stake in Rs 1,960 crore Lenskart block dealADIA-backed Platinum Jasmine A 2018 Trust sold a 2.3% stake in Lenskart through a Rs 1,960 crore block deal. The transaction attracted stro...
- Nifty eyes 23,516 breakout; Vinay Rajani flags key levels, recommends Pidilite and Aditya Birla AMCThe Nifty is at a crucial technical point. It faces resistance at 23,516 and support at 23,100. A breakout above resistance will confirm th...
- Lenskart Solutions sees Rs 1,862-crore block deal; ADIA likely sellerEyewear retailer Lenskart Solutions experienced a significant block deal valued at Rs 1,862 crore. Abu Dhabi Investment Authority, through ...
- ADIA to sell 2.3% Lenskart stake in Rs 1,944 crore block dealAbu Dhabi Investment Authority is set to divest a 2.3% stake in Lenskart for approximately Rs 1,944 crore via a block deal. This follows So...
- ADIA to sell Rs 1,944 crore Lenskart stake days after SoftBank exitAbu Dhabi Investment Authority (ADIA) is set to divest up to 2.3% of its stake in eyewear retailer Lenskart for approximately Rs 1,944 cror...
- Promoter sells Rs 1,024 crore worth of Ajanta Pharma shares in block deal to Kotak MF and ABSL MFA promoter entity of Ajanta Pharma sold shares worth over Rs 1,024 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya B...
- Explained: How AI mania has thrown India Inc out of MSCI EM's top 10 and world's top 100 listIndian companies are no longer in the top 10 of the MSCI Emerging Markets Index. A surge in AI stocks has shifted global capital. Taiwan an...
- GSK in talks to buy cancer biotech Nuvalent for more than $9 billionBritish drug giant GSK is reportedly in talks to acquire cancer drugmaker Nuvalent. The deal could be worth over nine billion dollars. Disc...
- Stocks in news: Bharti Airtel, Vodafone Idea, NLC India, Motilal Oswal, HCL TechIndian markets saw a sharp decline on Monday amid global worries and geopolitical tensions. Nifty moved closer to a key support level. Seve...
- Promoter entities sell Rs 153 crore worth shares in Motilal Oswal block deal; HDFC Life picks up stakeTwo promoter-group charitable entities of Motilal Oswal Financial Services sold shares worth about Rs 153 crore through block deals, with H...
- Lenskart shares in focus after Viridian completes stake transfer from Copthall MauritiusHong Kong-based Viridian Asia Opportunities Master Fund acquired an 18.96 lakh share stake in Lenskart Solutions for Rs 96 crore. This foll...
- Four mutual funds restrict large inflows into gold ETFs and FoFs; Rs 25 crore cap imposedSouth Korea and Taiwan are facing market pressure despite strong gains in semiconductor giants driving the AI boom. Heavy concentration in ...
- Retail investors can play on as AMCs cap gold betsThree major asset management companies have imposed purchase restrictions on large investors in gold mutual fund schemes. This move aims to...
- Nippon India Mutual Fund limits subscription in Gold BeES and gold savings fundNippon India Mutual Fund has imposed temporary subscription limits on Nippon India ETF Gold BeES and Nippon India Gold Savings Fund from Ju...
- ICICI Prudential Mutual Fund restricts subscription in ICICI Prudential Gold ETFICICI Prudential Mutual Fund has restricted subscriptions exceeding Rs 25 crore in its Gold ETF, becoming the second fund house to do so af...
- HDFC Mutual Fund limits subscription in its gold ETF and FoF. What this means for investors?HDFC Mutual Fund has temporarily restricted large lump-sum investments in its Gold ETF and Gold ETF Fund of Fund amid surging gold prices a...
- Feroze Azeez sees better risk-reward in equities than gold despite global uncertaintyHDFC Mutual Fund's new investment limits on gold ETFs and funds are sparking debate on investor behavior and asset allocation. Expert Feroz...
- Alkem Labs sees Rs 930 crore block deal as promoter family entities pare stake; Goldman, Morgan Stanley among key buyersAlkem Laboratories shares experienced significant block deals totaling Rs 930 crore. Promoter family entities divested shares to a group of...
Load More
